Optimi Health Corp. Receives Health Canada Psychedelic Research Exemption and Files Preliminary Prospectus for Initial Public Offering of Units
January 15, 2021 09:30 ET | Source: Optimi Health Corp. Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 15, 2021 (GLOBE NEWSWIRE) Optimi Health Corp. (“
Optimi” or the “
Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that it has filed a preliminary prospectus (the “
Preliminary Prospectus”) with the securities regulatory authorities in each of the provinces of Canada, except Quebec, for an initial public offering of units of the Company (the “
Units”) for gross proceeds of C$10,000,000 to C$15,000,000 (the “